EN
Human Haptoglobin, Mixed Type, Low Endotoxin Level
Native whole molecule mixture of Phenotypes 1-1, 2-1, 2-2 purified from large multiple donor pool
Product Overview, Sizes and Prices | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Proteins Synonyms: Zonulin, HPT, HP, BP, HP2ALPHA2, HPA1S Source: Human Plasma Purity: ≥ 95% by SDS-PAGE Endotoxin Level: < 2 EU/mg Physical State: Salt-free lyophilized solid. Manufacturer: |
|
|||||||||||||
Athens Research & Technology
Produktdetails
Synonyms
Zonulin, HPT, HP, BP, HP2ALPHA2, HPA1S
Description of Human Haptoglobin, Mixed Type, Low Endotoxin Level
Human Haptoglobin, Mixed Type, Low Endotoxin Level is a Hp 1-1: 86000 Da; Hp 2-1: 200000 Da; Hp 2-2: 400000 Da protein. Haptoglobin is a major acute-phase plasma glycoprotein present at concentrations of 100–300 mg/dL, primarily synthesized in the liver. Its central function is to bind free hemoglobin released during red blood cell breakdown, thereby preventing iron loss through the kidneys and reducing hemoglobin-driven oxidative tissue damage. This hemoglobin–haptoglobin complex is rapidly cleared by macrophages via the CD163 receptor, facilitating iron recycling and modulating antioxidant and anti-inflammatory pathways. Haptoglobin also influences immune responses, interacting with neutrophils, lymphocytes, and dendritic cells to regulate inflammation and adaptive immunity. Humans exhibit three main haptoglobin phenotypes-Hp 1-1, Hp 2-1, and Hp 2-2-arising from genetic polymorphisms. Hp 1-1 demonstrates the highest hemoglobin-binding and antioxidant efficiency, while Hp 2-2 is least effective, which may explain its association with increased risk and severity of conditions such as cardiovascular disease, diabetes, and epilepsy. Notably, the Hp 2-2 phenotype is linked to poorer outcomes in coronary artery disease and more frequent epilepsy attacks, likely due to reduced antioxidant protection in neural tissues. Clinically, haptoglobin serves as a sensitive biomarker for hemolytic anemia, liver function, and as a potential prognostic marker in cancer and inflammatory diseases. Therapeutically, recombinant haptoglobin is being explored for treating hemolysis-related complications and as a neuroprotective agent following subarachnoid hemorrhage.
Source
Human plasma non-reactive for HBsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests
Storage
For long term, store Human Haptoglobin, Mixed Type, Low Endotoxin Level at ≤ -20°C.
Applications
Animal Studies, Cell Based Assays, ELISA, Protein Chemistry, Inflammation, Sickle Cell Anemia, Glycosylation, Stroke, Central Nervous System Injury, Diabetes, Cardiovascular Disease, In Vitro Diagnostic, Iron Metabolism, Cancer.
Citations/Publications
Chen-Roetling, J., et al., (2016), ''Haptoglobin increases the vulnerability of CD163-expressing neurons to hemoglobin', J. Neurochem., 139(4): pp 586-595.Available at: doi: 10.1111/jnc.13720.
NCBI: https://www.ncbi.nlm.nih.gov/protein/P00738
Shipped with ice packs
Usage: For research use only. Not for use in diagnostic or therapeutic procedures. Not for human use.
To buy Human Haptoglobin, Mixed Type, Low Endotoxin Level please click on the Shopping List Symbol right from the indicated price. This will add Human Haptoglobin, Mixed Type, Low Endotoxin Level to your Shopping List. You can then click on the button »Shopping List & Order Form« to ask for a quote. We will send you your quote as soon as possible. Our offer will include institutional discounts where applicable.
For business customers only. All prices are net prices (excluding VAT). Final prices in our quote will contain VAT plus shipping costs if applicable. For further information please go to our Shipping page.
Errors, changes and availability excepted.
Payment Methods
Paying by bank transfer
